Inhibrx, Inc. Ex-distribution When-Issued (INBXV)
Delisted
17 Jun 2025
NASDAQ (NMS) NASDAQ (NMS) Primary $
30. 85
0
0%
$
1.57B Market Cap
- P/E Ratio
- Div Yield
277,651 Volume
- Eps
$ 30.85
Previous Close Day Range
30.85 31.11
Year Range
30.85 31.11
Want to track INBXV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.
INBXV Chart
Inhibrx, Inc. Ex-distribution When-Issued (INBXV) FAQ
What does "Delisted" mean?
Inhibrx, Inc. Ex-distribution When-Issued has been removed from the exchange and is no longer publicly traded.
What was the last recorded dividend?
No dividend payments were recorded prior to delisting.
How long did the company pay dividends?
The company did not have a dividend payment history.
Were there any stock splits?
No stock splits were recorded prior to delisting.
What was the last known trading price?
The stock last traded at $30.85 on Jun 17, 2025 before being delisted.
Inhibrx, Inc. Ex-distribution When-Issued Profile
| Biotechnology Industry | Healthcare Sector | Mark Paul Lappe CEO | NASDAQ (NMS) Exchange | - ISIN |
| United States Country | 166 Employees | - Last Dividend | - Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
